It has been known for over a decade that patients with SLE exhibit evidence of type I Interferon signaling as reflected by increased Interferon Stimulated Genes (ISGs) in peripheral blood monocytes and elevated levels of the cytokine being produced by cells and measured across various tissues [44–46]. This evidence concerns the gene STING1 and systemic lupus erythematosus.